Large-scale testing (Phase 3)Active Not RecruitingNCT06746116
What this trial is testing
Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain
Who this might be right for
Advanced or Recurrent Endometrial Cancer
AstraZeneca 45